erythrosine has been researched along with vidarabine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Damiano, RA; Hyndiuk, RA; Okumoto, M; Smolin, G; Valenton, M | 1 |
Egerer, I; Stary, A | 1 |
Butters, TD; Ganeshaguru, K; Gerrard, G; Mehta, AB | 1 |
3 other study(ies) available for erythrosine and vidarabine
Article | Year |
---|---|
Treatment of vaccinial keratitis with vidarabine.
Topics: Animals; Corneal Ulcer; Disease Models, Animal; Fluoresceins; Idoxuridine; Keratitis; Purine Nucleosides; Rabbits; Vaccinia virus; Vidarabine; Virus Diseases | 1976 |
Erosive-ulcerative herpes simplex blepharitis.
Topics: Adolescent; Adult; Aged; Animals; Antiviral Agents; Blepharitis; Child; Chloramphenicol; Double-Blind Method; Eyelid Diseases; Female; Fluoresceins; Humans; Keratitis, Dendritic; Male; Mice; Middle Aged; Vidarabine | 1980 |
Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity.
Topics: 1-Deoxynojirimycin; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 1; B-Lymphocytes; Cell Line, Tumor; Chlorambucil; Cytotoxins; Enzyme Inhibitors; Female; Fluoresceins; Fluorescent Dyes; Formazans; Glucosyltransferases; Humans; Inhibitory Concentration 50; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Models, Chemical; Molecular Structure; Tetrazolium Salts; Vidarabine | 2009 |